5108
C. Wang et al. / Tetrahedron 65 (2009) 5102–5109
(100 MHz, CDCl3):
d
21.0 (overlapping CH3, CH3Ts), 21.6 (over-
8.5.1. 4-Methyl-N-(2-(1-(pyrrolidin-1-yl)allyl)phenyl)-
lapping CH3, CH3Ts), 45.5 (CH2), 123.8 (]CHCH2), 126.0 (]CH),
126.7 (Ar CH), 127.0 (Ar CH), 127.3 (Ar CH), 128.7 (Ar CH), 129.0 (Ar
CH), 129.3 (quat. Ar C), 132.4 (quat. Ar C), 136.4 (quat. Ar C), 136.5
(quat. Ar C), 143.3 (quat. Ar C). FTIR (CH2Cl2): nmax 3053, 2986, 1489,
1421, 1271, 1258, 895. HRMS calcd for C17H18NO2S [Mþ] 300.1058,
found 300.1059.
benzenesulfonamide (10a)
1H NMR (400 MHz, CDCl3):
d 1.85 (4H, s), 2.39 (3H, s, CH3Ts and
CH2, overlapping), 2.55 (2H, br s), 3.69 (1H, d, J¼8.84 Hz), 4.96 (1H,
d, J¼9.92 Hz), 5.09 (1H, d, J¼16.84 Hz), 5.87–5.78 (1H, m), 6.93 (1H,
d, J¼7.16 Hz), 6.99 (1H, d, J¼7.16 Hz), 7.19–7.15 (1H, m), 7.28–7.25
(1H, m), 7.53 (1H, d, J¼8.04 Hz), 7.80 (1H, d, J¼8.04 Hz),11.87 (1H, br
s). 13C NMR (100 MHz, CDCl3):
d 21.5, 23.6, 51.8, 74.3, 117.2, 118.0,
8.3.2. 6-Methoxy-3-methyl-1-tosyl-1,2-dihydroquinoline (5g)
123.0, 127.0, 128.2, 128.7, 128.8, 129.5, 136.4, 137.1, 137.8, 143.4. FTIR
(CH2Cl2): nmax 2935, 1494, 1338, 1151, 756, 655. HRMS calcd for
C20H24N2O2SNa [MþNa] 379.1456, found 379.1451.
1H NMR (400 MHz, CDCl3):
d 1.65 (3H, s, CH3), 2.36 (3H, s,
CH3Ts), 3.81 (3H, s, OCH3), 4.23 (2H, s, CH2), 5.66 (1H, s, ]CH), 6.41
(1H, d, J¼2.8 Hz, Ar CH), 6.79 (1H, dd, J¼8.8, 2.8 Hz, Ar CH), 7.09 (2H,
d, J¼8.1 Hz, Ar CH), 7.25 (2H, d, J¼8.1 Hz, Ar CH), 7.61 (1H, d,
8.5.2. 4-Methyl-N-(2-(1-(piperidin-1-yl)allyl)phenyl)-
J¼8.8 Hz, Ar CH). 13C NMR (100 MHz, CDCl3):
d
20.8 (CH3), 21.6
benzenesulfonamide (10b)
(CH3Ts), 49.6 (CH2), 55.5 (OCH3), 110.8 (Ar CH), 112.0 (Ar CH), 121.0
(]CH), 126.5 (quat. Ar C), 126.9 (Ar CH), 128.2 (Ar CH), 128.9 (Ar
CH), 131.8 (quat. Ar C), 134.4 (]C), 135.8 (quat. Ar C), 143.3 (quat. Ar
C), 158.3 (quat. Ar C). FTIR (CH2Cl2): nmax 3052, 2929, 1346, 1259,
1165. HRMS calcd for C18H19NO3SNa [MþNa] 352.0984, found
352.0982.
1H NMR (400 MHz, CDCl3):
d 1.49 (2H, br s), 1.68 (4H, m), 2.40
(3H, s, CH3Ts), 2.49 (4H, br s), 3.62 (1H, d, J¼9.60 Hz), 5.08 (2H, dd,
J¼18.50, 13.50 Hz), 5.76 (1H, dt, J¼16.9, 9.9 Hz), 6.99–6.95 (2H, m),
7.20–7.16 (1H, m), 7.28–7.25 (2H, m), 7.47 (1H, d, J¼8.00 Hz), 7.77
(2H, d, J¼7.77 Hz), 12.18 (1H, br s). 13C NMR (100 MHz, CDCl3):
d
21.5, 24.3, 26.0, 51.1, 74.1, 118.9, 119.4, 123.4, 126.9, 128.1, 128.6,
129.0, 129.6, 134.4, 137.5, 138.2, 143.3. FTIR (CH2Cl2): nmax 2935,
1492, 1340, 1150, 754. HRMS calcd for C21H26N2NaO2S [MþNa]
393.1613, found 393.1611.
8.4. General procedure for decarboxylative cycloadditions
In a Schlenk tube under argon, Pd(PPh3)4 (0.05 mmol), vinyl
benzoxazinanone 1 (1 mmol), and the electrophile (1–1.1 mmol)
were dissolved in 5 mL of methylene chloride. The resulting yel-
low solution was stirred at ambient temperature under Ar until
reaction completion was indicated by TLC (generally 4–6 h). Fol-
lowing solvent evaporation under reduced pressure, the crude
product was purified via flash chromatography (SiO2, 5:1 hexane/
ethyl acetate).
8.5.3. N-(2-(1-(Benzylamino)allyl)phenyl)-4-
methylbenzenesulfonamide (10c)
1H NMR (400 MHz, CDCl3):
d 2.37 (3H, s, CH3Ts), 3.65 (1H, d,
J¼13.04 Hz), 3.74 (1H, d, J¼13.04 Hz), 4.14 (1H, d, J¼6.76 Hz), 5.05
(2H, t, J¼10.40 Hz), 5.84–5.76 (1H, m), 7.02–6.97 (2H, m), 7.21–716
(3H, m), 7.35 (3H, m), 7.40 (2H, d, J¼7.60 Hz), 7.60 (1H, d, J¼7.60 Hz),
7.66 (2H, d, J¼7.60 Hz), 11.31 (1H, br s). 13C NMR (100 MHz, CDCl3):
d
21.4, 50.9, 65.1, 117.1, 119.3, 123.4, 127.1, 127.5, 127.8, 128.3, 128.5,
128.7, 129.4, 136.9, 137.5, 138.4, 143.2. FTIR (CH2Cl2): nmax 3028,
1494, 1150, 933, 756. HRMS calcd for C23H25N2O2SNa [MþH]
393.1637, found 393.1630.
8.4.1. 2-Phenyl-1-tosyl-4-vinyl-1,2-dihydroquinoline-3,3(4H)-
dicarbonitrile (7a)
1H NMR (400 MHz, CDCl3):
d 2.47 (3H, s, CH3Ts), 2.56 (1H, d,
J¼9.6 Hz, CHCH]), 5.09 (1H, d, J¼16.8 Hz, CH]CH(H)trans), 5.61
(1H, dd, J¼10.1, 1.0 Hz, CH]CH(H)cis), 5.77 (1H, s, CHPh), 5.91 (1H,
dt, J¼16.8, 10.1 Hz, CH]CH2), 7.17 (1H, d, J¼7.7 Hz, Ar CH), 7.29 (2H,
d, J¼7.7 Hz, Ar CH), 7.39–7.51 (5H, m, Ar CH), 7.51–7.67 (4H, m, Ar
CH), 7.89 (1H, dd, J¼7.99, 1.04 Hz, Ar CH). 13C NMR (100 MHz,
8.5.4. (E)-4-Methyl-N-(3-(2-(4-methylphenylsulfonamido)-
phenyl)allyl)-N-phenylbenzenesulfonamide
1H NMR (500 MHz, CDCl3):
d 2.41 (3H, s, CH3Ts), 2.47 (3H, s,
CH3Ts), 4.23 (2H, d, J¼6.5 Hz), 5.83 (1H, dt, J¼15.7, 6.4 Hz), 6.10 (1H,
br s), 6.21 (1H, d, J¼15.70 Hz), 7.10–7.06 (3H, m), 7.18–7.13 (2H, m),
7.29–7.22 (3H, m), 7.30 (1H, br s), 7.37–7.32 (2H, m), 7.52 (2H, d,
J¼8.25 Hz), 7.56 (2H, d, J¼8.25 Hz). 13C NMR (100 MHz, CDCl3):
CDCl3):
d 21.6 (CH3Ts), 49.1 (CHCH]), 50.0 (CCN2), 65.8 (CHPh),
111.2 (CN), 113.9 (CN), 125.0 (]CH2), 126.8 (Ar CH), 127.0 (Ar CH),
127.3 (Ar CH), 128.2 (Ar CH), 128.6 (Ar CH), 129.2 (Ar CH), 129.3
(CH]CH2), 129.6 (Ar CH), 130.0 (Ar CH), 130.2 (Ar CH), 131.6 (quat.
Ar C), 134.5 (quat. Ar C), 135.1 (quat. Ar C), 136.7 (quat. Ar C), 145.1
(quat. Ar C). FTIR (CDCl3): nmax 3053, 2986, 2305, 1597, 1483, 1421,
1262, 895. HRMS calcd for C26H21N3O2SNa [MþNa] 462.1252, found
462.1251. HPLC, Diacel Chiralpak AD-H column (96% hexane/IPA,
1.0 mL/min), tR (S,S)¼22.8 min, tR (R,R)¼32.1 min. N-nosyl derivative:
1-(4-nitrophenylsulfonyl)-2-phenyl-4-vinyl-1,2-dihydroquinoline-
d
21.6 (CH3Ts), 21.6 (CH3Ts), 52.9, 124.5, 126.3, 127.2, 127.3, 127.8,
128.1, 128.6, 128.6, 128.7, 128.8, 129.1, 129.5, 129.7, 131.4, 133.2,
135.19, 136.4, 139.2, 143.7, 143.9. HRMS calcd for C29H28N2O4S2Na
[MþNa] 555.1388, found 555.1351.
References and notes
3,3(4H)-dicarbonitrile. 1H NMR (400 MHz, CDCl3):
d 3.02 (1H, d,
1. Wang, C.; Tunge, J. A. Org. Lett. 2006, 8, 3211–3214.
2. (a) Kuhn, O.; Mayr, H. Angew. Chem., Int. Ed. 1999, 38, 343–346; (b) Lemek, T.;
Mayr, H. J. Org. Chem. 2003, 68, 6880–6886.
3. For related cycloadditions see: (a) Aoyagi, K.; Nakamura, H.; Yamamoto, Y.
J. Org. Chem. 2002, 67, 5977–5980; (b) Sekido, M.; Aoyagi, K.; Nakamura, H.;
Kabuto, C.; Yamamoto, Y. J. Org. Chem. 2001, 66, 7142–7147.
4. Wang, C.; Tunge, J. A. J. Am. Chem. Soc. 2008, 130, 8118–8119.
5. Wojciechowski, K. Eur. J. Org. Chem. 2001, 3587–3605.
J¼9.5 Hz, CHCH]), 5.33 (1H, d, J¼16.8 Hz, CH]CH(H)trans), 5.69
(1H, d, J¼10.2 Hz, CH]CH(H)cis), 5.86 (1H, s, CHPh), 5.95 (1H, ddd,
J¼16.6, 10.2, 9.5 Hz, CH]CH2), 6.97–8.26 (overlapping Ar CH).
8.5. General procedure for decarboxylative amination
6. Consonni, R.; Dalla Croce, P.; Ferraccioli, R.; La Rosa, C. J. Chem. Soc., PerkinTrans.1
1996, 1809–1814.
Pd(PPh3)4 (0.012 mmol), vinyl benzoxazinanone 3a (0.2 mmol),
and the amine (0.3 mmol) were dissolved in methylene chloride
(1.0 mL) in a well-sealed reaction vial under argon. The resulting
solution was stirred at ambient temperature under Ar until reaction
completion was indicated by TLC (generally 30 min to 1 h). Fol-
lowing solvent evaporation under reduced pressure, the crude
product was purified via flash chromatography (SiO2, 4:1 hexane/
ethyl acetate).
7. Chong, P. Y.; Janicki, S. Z.; Petillo, P. A. J. Org. Chem. 1998, 63, 8515–8521.
8. Rauno, G.; Luis, J.; Concepcion, P.; Jesus, H. R. Tetrahedron 1989, 45, 203–214.
9. For a related macrocyclic triflamide see: Satake, A.; Ishii, H.; Shimizu, I.; Inoue,
Y.; Hasegawa, H.; Yamamoto, A. Tetrahedron 1995, 51, 5331–5340.
10. (a) Arisawa, M.; Terada, Y.; Takahashi, K.; Nakagawa, M.; Nishida, A. J. Org. Chem.
2006, 71, 4255–4261; (b) Larock, R. C.; Hightower, T. R.; Hasvold, L. A.; Peterson,
K. P. J. Org. Chem. 1996, 61, 3584–3585; (c) Weissman, A.; Muren, J. F. J. Med.
Chem. 1971, 14, 49–53.
11. Fugami, K.; Miura, K.; Morizawa, Y.; Oshima, K.; Utimoto, K.; Nozaki, H. Tetra-
hedron 1989, 45, 3089–3098.